Jane Street Group LLC bought a new position in Balchem Co. (NASDAQ:BCPC) in the second quarter, Holdings Channel reports. The firm bought 2,275 shares of the basic materials company’s stock, valued at approximately $227,000.
Other large investors have also recently added to or reduced their stakes in the company. CWM LLC purchased a new position in Balchem in the second quarter valued at $31,000. Krane Funds Advisors LLC purchased a new stake in Balchem in the second quarter worth $60,000. Tower Research Capital LLC TRC purchased a new stake in Balchem in the second quarter worth $65,000. Clarus Wealth Advisors purchased a new stake in Balchem in the second quarter worth $104,000. Finally, NN Investment Partners Holdings N.V. purchased a new stake in Balchem in the second quarter worth $164,000. 86.47% of the stock is owned by institutional investors and hedge funds.
A number of research firms have issued reports on BCPC. Zacks Investment Research raised Balchem from a “sell” rating to a “hold” rating in a research report on Monday, October 7th. HC Wainwright reaffirmed a “buy” rating and issued a $95.00 price target (down from $110.00) on shares of Balchem in a report on Monday, August 5th. Finally, BidaskClub raised Balchem from a “hold” rating to a “buy” rating in a report on Friday, October 4th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $108.75.
Shares of Balchem stock traded down $0.65 during trading hours on Monday, reaching $99.09. The company had a trading volume of 421 shares, compared to its average volume of 108,486. Balchem Co. has a one year low of $73.16 and a one year high of $105.99. The business has a fifty day simple moving average of $95.93 and a 200 day simple moving average of $96.09. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.73 and a quick ratio of 2.63. The firm has a market cap of $3.14 billion, a PE ratio of 32.70 and a beta of 1.22.
Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Thursday, August 1st. The basic materials company reported $0.77 EPS for the quarter, topping the Zacks’ consensus estimate of $0.69 by $0.08. Balchem had a return on equity of 13.87% and a net margin of 12.27%. The firm had revenue of $161.60 million during the quarter, compared to analyst estimates of $163.14 million. During the same period last year, the company earned $0.76 earnings per share. The business’s revenue for the quarter was down 1.3% on a year-over-year basis. On average, research analysts forecast that Balchem Co. will post 3.06 EPS for the current year.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Read More: What is the Rule of 72?
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.